Clinical application of prostaglandin E1 in cases of occlusive arterial disease.
For the present time, intraarterial infusion of PGE1 is the treatment of choice for impending gangrene. But because of its technical difficulties and unpleasant side effects, mentioned earlier, intravenous administration of PGE1 should be considered in some cases.
D000527:Alprostadil / Q000627:therapeutic use* / Q000633:toxicity; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans
D000527:Alprostadil